BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
BioInvent International Profit Margin (Quarterly) : -964.0% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -964.0% |
| March 31, 2026 | -888.2% |
| December 31, 2025 | -4.17K% |
| September 30, 2025 | -3.89K% |
| June 30, 2025 | 19.59% |
| March 31, 2025 | -528.7% |
| December 31, 2024 | -547.0% |
| September 30, 2024 | -761.8% |
| June 30, 2024 | -2.98K% |
| March 31, 2024 | -1.31K% |
| December 31, 2023 | -634.2% |
| September 30, 2023 | -265.2% |
| June 30, 2023 | -674.7% |
| March 31, 2023 | -453.7% |
| December 31, 2022 | -379.5% |
| September 30, 2022 | -356.4% |
| June 30, 2022 | 61.81% |
| March 31, 2022 | -406.7% |
| December 31, 2021 | -1.61K% |
| September 30, 2021 | -2.09K% |
| June 30, 2021 | -1.08K% |
| March 31, 2021 | -1.29K% |
| December 31, 2020 | 28.88% |
| September 30, 2020 | -202.1% |
| June 30, 2020 | -251.4% |
| Date | Value |
|---|---|
| March 31, 2020 | -195.3% |
| December 31, 2019 | -161.3% |
| September 30, 2019 | -205.6% |
| June 30, 2019 | -99.70% |
| March 31, 2019 | -159.6% |
| December 31, 2018 | -314.9% |
| September 30, 2018 | -317.3% |
| June 30, 2018 | -441.3% |
| March 31, 2018 | -219.8% |
| December 31, 2017 | -245.9% |
| September 30, 2017 | -300.1% |
| June 30, 2017 | -206.5% |
| March 31, 2017 | -172.2% |
| December 31, 2016 | -23.66% |
| September 30, 2016 | -3.51K% |
| June 30, 2016 | -262.9% |
| March 31, 2016 | 1.11% |
| December 31, 2015 | -211.3% |
| September 30, 2015 | -1.36K% |
| June 30, 2015 | -689.2% |
| March 31, 2015 | -3.54K% |
| December 31, 2014 | -1.70K% |
| September 30, 2014 | -93.16% |
| June 30, 2014 | 11.45% |
| March 31, 2014 | -1.07K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 23.02% |
| Hansa Biopharma AB | -541.7% |
| BioArctic AB | -4.51% |
| Swedish Orphan Biovitrum AB | 14.00% |
| Diamyd Medical AB | -16.72K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -89.41% |
| Return on Assets | -75.34% |
| Return on Invested Capital | -87.55% |
| Operating Margin (Quarterly) | -980.5% |
| Return on Net Operating Assets | -967.8% |